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Abstract
Introduction:  The  present  study  was  designed  to  compare  three-dimensional  speckle  track-
ing echocardiography  (3DSTE)-derived  left  atrial  (LA)  volumetric,  volume-based  functional  and
strain  parameters  between  patients  with  hypereosinophilic  syndrome  (HES)  and  matched  con-
trols.
Methods:  A total  of  10  HES  patients  and  19  age-  and  gender-matched  healthy  controls
were included  in the  study.  Complete  two-dimensional  Doppler  echocardiography  and  3DSTE
were  performed  in  all HES  cases  and  controls.
Results:  Signiﬁcantly  increased  maximum  (72.9±38.8  ml  vs.  45.6±15.5  ml,  p=0.01)  and  min-
imum  (46.3±33.3  ml  vs.  26.0±15.0  ml,  p=0.03)  LA  volumes  and  LA  volume  before  atrial
contraction  (62.0±36.0  ml  vs.  36.5±16.6  ml,  p=0.01)  were  found  in HES  patients  compared  to
controls.  Both  peak  global  (18.3±6.7%  vs.  25.6±9.0%,  p=0.03)  and  mean  segmental  (22.2±6.0%
vs.  31.0±12.1%,  p=0.04)  circumferential  strains  were  signiﬁcantly  reduced  in HES  patients,
suggesting  decreased  LA  reservoir  function.
Conclusion:  Increased  LA volumes  can  be demonstrated  in  HES  patients,  accompanied  by
reduced LA peak  circumferential  strain as  assessed  by  3DSTE,  suggesting  LA  remodeling.
© 2016  Sociedade  Portuguesa  de Cardiologia.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.
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Caracterizac¸ão  da  disfunc¸ão  auricular  esquerda  na  síndrome  hipereosinofílica  --
visão  da  análise  de movimentos  do  corac¸ão  e  dos grandes  vasos  por ecocardiograﬁa
tridimensional  speckle  tracking  em  casos  patológicos  --  estudo  MAGYAR-Path
Resumo
Introduc¸ão:  O presente  estudo  foi concebido  para  comparar  parâmetros  volumétricos  auric-
ulares esquerdos  derivados  por  ecocardiograﬁa  tridimensional  speckle  tracking,  parâmetros
funcionais  e strain  baseados  no  volume  entre  doentes  com  síndrome  hipereosinofílica  e  contro-
los  equiparados.
Métodos:  Um total  de dez  doentes  HES  e  de  19  controlos  saudáveis,  equiparados  para  idade  e
género,  foram  incluídos  no  estudo.  O  estudo  completo  ecocardiográﬁco  bidimensional,  Doppler
e  3DSTE,  foi realizado  em  todos  os casos  HES  e  controlos.
Resultados:  Encontrou-se  em  doentes  com  HES,  comparativamente  com  os  controlos,  um
aumento signiﬁcativo  dos  volumes  auriculares  esquerdos  (72,9  ±  38,8  ml  versus  45,6  ±  15,5  ml,
p  =  0,01),  mínimo  (46,3  ± 33,3  ml  versus  26,0  ± 15,0  ml,  p  =  0,03)  e volume  auricular  esquerdo
antes  da  contrac¸ão  auricular  (62,0  ±  36,0  ml  versus  36,5  ± 16,6  ml,  p  =  0,01).  Ambos  strains
circunferenciais  pico,  global  (18,3  ±  6,7%  versus  25,6  ±  9,0%,  p  =  0,03)  e segmentar  médio
(22,2  ± 6,0%  versus  31,0  ± 12,1%,  p  = 0,04)  eram  signiﬁcativamente  reduzidos  em  doentes  HES,
sugerindo  diminuic¸ão  de  func¸ão  auricular  esquerda  de reservatório.
Conclusão:  O  aumento  de  volumes  auriculares  esquerdos  foi demonstrado  nos  doentes  HES,
sendo acompanhado  por  reduc¸ão  de strain  circunferencial  pico  da  aurícula  esquerda  conforme
avaliado  por  3DSTE,  sugerindo  remodelagem  auricular  esquerda.
© 2016  Sociedade  Portuguesa  de Cardiologia.  Publicado  por  Elsevier  España,  S.L.U.  Todos  os
direitos  reservados.
Introduction
Hypereosinophilic  syndrome  (HES) is  characterized  by  per-
sistently elevated  eosinophil  count  (>1500  cells/ml)  in
peripheral blood  for at least six  months,  and single-  or  mul-
tiple end-organ  damage  attributable  to  cytotoxic  injury  by
eosinophils.1 In  the  literature  the  overall  prevalence  of  car-
diovascular involvement  is  40--50%  of  HES  patients.1--3 The
early stage  of  cardiac  involvement  consists  of  eosinophilic
inﬁltration, followed  by  an intermediate  thrombotic  stage,
and ﬁnally  a  late  ﬁbrotic  stage.  An  enlarged  atrium  with
normal-sized left ventricle  is  a minor criterion  for  endomy-
ocardial ﬁbrosis.1 At  present  little  is  known  about  left  atrial
(LA) function  in HES.  Three-dimensional  (3D) speckle  track-
ing echocardiography  (3DSTE)  is  a  new non-invasive  clinical
tool for  volumetric  and  strain  analysis  of  the  left atrium.4
The  present  study  was  designed  to  compare  3DSTE-derived
LA volumetric,  volume-based  functional  and  strain  parame-
ters between  HES  patients  and  matched  controls.
Methods
Subjects
A total  of  10  HES  patients  were  included  in the present  study.
The diagnosis  of HES  was  conﬁrmed  in all patients  according
to the  available  guidelines.5 One  HES  patient  had  a  history  of
non-ST-elevation myocardial  infarction;  the  others  showed
no signiﬁcant  cardiac alterations  and  were  asymptomatic
at the  time  of  examination.  Their  results  were  compared
to  19  age-  and  gender-matched  healthy  controls.  Complete
two-dimensional (2D) Doppler  echocardiography  and  3DSTE
were performed  in  all  HES  patients  and controls.  The  present
work is  a part  of  the Motion  Analysis  of  the  heart  and  Great
vessels bY three-dimensionAl  speckle-tRacking  echocardiog-
raphy in  Pathological  cases  (MAGYAR-Path)  Study  (‘Magyar’
means ‘Hungarian’  in the  Hungarian  language),  carried  out
at  the  2nd  Department  of  Medicine  and Cardiology  Center,
Szeged, Hungary  to  validate  3DSTE-derived  parameters,  to
examine their  diagnostic  and  prognostic  signiﬁcance  and  to
compare them  to  other  known (patho)physiological  varia-
bles in pathological  cases.  The  protocol  was  approved  by  the
institutional review  board,  conforming  to  the  ethical  guide-
lines of the 1975  Declaration  of Helsinki,  and  each  subject
provided written  informed  consent.
Two-dimensional  Doppler  and tissue  Doppler
echocardiography
Transthoracic  imaging  was  performed  by  experienced  inves-
tigators using  a  1--5  MHz  PST-30SBP  phased-array  transducer
in a  Toshiba  ArtidaTM cardiac  ultrasound  system  (Toshiba
Medical Systems,  Tokyo,  Japan).  Complete  two-dimensional
echocardiography was  undertaken  with  the  patient  in  left
lateral decubitus  position,  using  both  apical  and  paraster-
nal views  in all  cases.  Ejection  fraction  was  measured  in
parasternal long-axis  view  by  the Teichholz  method.6 Color
Doppler echocardiography  was  used  to  visually  quantify
degree of  mitral  regurgitation  (MR).  Tissue  Doppler  echo-
cardiography was  used to  calculate  the E/E′ ratio  following
pulsed Doppler-derived  mitral  inﬂow  E/A  measurements.
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Three-dimensional  speckle  tracking
echocardiography
3DSTE  datasets  were  acquired  from  an  apical  window  using
a 1-4  MHz  matrix  phased-array  transducer  (PST-25SX).4 Fol-
lowing optimization  of  gain  setting,  full  volume  mode was
used over  six  consecutive  cardiac  cycles  during  a  single
breath-hold. The  volume data  were  stored  in raw  data  for-
mat for  further  analysis.  LA quantiﬁcations  were  performed
using 3D  Wall  Motion  Tracking  software,  version  2.7  (Toshiba
Medical Systems,  Tokyo,  Japan).  Each 3D  dataset  was  dis-
played in  multiple  planes,  including  apical  two-  (AP2CH)
and four-chamber  (AP4CH)  views,  and  three  short-axis  views
at different  LA levels  from  the base  to  the  apex. Several
reference points  on the LA endocardium  were  set  by  the
examiner in  AP2CH  and  AP4CH  views.  The  ﬁrst  points  were
set at  the  edge of  the septal  mitral  valve  annulus  (at  the
origin of  the  anterior  mitral  leaﬂet),  then  markers  were
placed in  counterclockwise  rotation  around  the  LA to  the
lateral mitral  valve  annulus  (to  the  origin  of  the  posterior
leaﬂet) in AP4CH  view.  During  the studies  the LA  appendage
and the  pulmonary  veins  were  excluded  from the  LA cavity.
Measurements were  performed  ﬁrst in AP4CH  view,  then  in
AP2CH view.  After detection  of  the LA  myocardial  borders  at
the end-diastolic  reference  frame,  the  user  could  correct
the  LA  shape,  if  necessary.  3D  wall  motion  tracking  was  then
automatically performed  through  the entire  cardiac  cycle.
Three-dimensional  speckle  tracking
echocardiography for left  atrial  volumetric
measurements
From  time  curves  of  global  LA volume  changes,  maxi-
mum (Vmax)  and  minimum  (Vmin)  LA  volumes  and  LA  volume
before atrial  contraction  (VpreA) were measured  from  the  3D
echocardiographic datasets  just before  mitral  valve  opening
(end-systole), just  before  mitral  valve  closure (end-diastole)
and at time  of  P wave  on  ECG  (early diastole),  respectively
(Figure 1).7--10 LA  function  consists  of  three  phases:  the  sys-
tolic reservoir  phase, and the  diastolic  passive  (conduit)
and active emptying  (booster  pump)  phases.  To  character-
ize these functions,  stroke  volumes  and  emptying  fractions
were calculated  from  the above-mentioned  volumes:
LA  stroke  volumes:
-  Total  atrial  stroke  volume  (TASV):  Vmax−Vmin (reservoir
function)
- Passive  atrial  stroke  volume (PASV):  Vmax−VpreA (conduit
function)
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Figure  1  Images  from  three-dimensional  full-volume  dataset  showing  left  atrium:  apical  4-chamber  (A)  and  2-chamber  views  (B)
and  short-axis  views  at  basal  (C3),  mid-  (C5)  and  superior  (C7)  left  atrial  level are  demonstrated  together  with  left  atrial  volumetric
data  and  a three-dimensional  cast  of  the  left  atrium.  Time-segmental  strain  curves  of  all  16  left  atrial  segments  and  global  left
atrial  volume  changes  throughout  the  cardiac  cycle  are  also  presented.  White  arrow:  peak  strain.  LA:  left  atrium;  LV:  left  ventricle;
RA:  right  atrium;  RV:  right  ventricle;  Vmax,  Vmin and  VpreA:  maximum  and  minimum  left  atrial  volumes  and  left  atrial  volume  before
atrial contraction,  respectively.
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Table  1  Clinical  data  of  patients  with  hypereosinophilic  syndrome.
Case  Year  of
birth
Year of
diagnosis
Organ  involvement  Hepatomegaly/
splenomegaly
Cardiac disease
1  1961  2013  Duodenal  eosinophilia  Splenomegaly  -
2  1938  2009  -  -  -
3  1966  2010  -  -  -
4  1945  2011  Tissue  eosinophilia  -  -
5  1936  2013  -  -  NSTEMI  (2013)
6  1940  2009  Eosinophilic  dermatitis  -  -
7  1966  2011  Sensory-motor  neuropathy,  pulmonary
involvement,  sural  nerve
granulomatous necrotizing  vasculitis
Splenomegaly  -
8  1954  2013  -  -  -
9  1961  2002  -  -  -
10 1941  2014  Asthma,  vasculitis  -  -
NSTEMI: non-ST-elevation myocardial infarction.
-  Active  atrial  stroke  volume  (AASV):  VpreA−Vmin (booster
pump/active contraction  function).
LA  emptying  fractions:
-  Total  atrial  emptying  fraction  (TAEF):  TASV/Vmax×100
(reservoir  function)
-  Passive  atrial  emptying  fraction  (PAEF):  PASV/Vmax×100
(conduit  function)
-  Active  atrial  emptying  fraction  (AAEF):  AASV/VpreA×100
(booster  pump/active  contraction  function).
Three-dimensional  speckle  tracking
echocardiography for left  atrial  strain
measurements
From  the  same  3D  echocardiographic  datasets,  time  curves
of one-directional  radial  (RS),  longitudinal  (LS) and  circum-
ferential (CS)  strains  were  also  generated  for each segment
using the  16-segment  model  obtained  for  the left  ventricle
(Figure 1).10--12 Moreover,  due  to  the ability  of  3DSTE  to  cal-
culate complex  strains,  area  strain  (ratio  of endocardial  area
change during  the  cardiac  cycle)  and  3D  strain  (strain  in the
wall thickening  direction,  combination  of  one-directional
strains) were  also  measured.  On  each  time-segmental  strain
curve, peak  strains  representing  characteristics  of the reser-
voir phase  of  LA  function  were  measured.  Global  strains
were calculated  by  the software  considering  the whole  LA,
while mean  segmental  strains  were  obtained  as  the mean
of strains  of 16  segments.  The  software  calculated  these
parameters automatically.
Statistical  analysis
Continuous  variables  are  expressed  as  mean  ±  standard
deviation. All  statistical  tests  were  two-sided  and a  p  value
<0.05 was  regarded  as  statistically  signiﬁcant.  Continuous
variables were  assessed  by  the unpaired  Student’s  t test,
while categorical  variables  were  assessed  by  the  chi-square
test and  Fisher’s  exact  test.  Correlations  were  established
by calculation  of  Pearson  correlation  coefﬁcients.  The
statistical  analysis  was  performed  with  MedCalc  software
(MedCalc, Inc.,  Mariakerke,  Belgium).
Results
The  clinical  data  of  each  patient  including  organ  involve-
ment are  presented  in Table  1.  Only  one patient  had  a history
of cardiac  disease  (non-ST-elevation  myocardial  infarction).
The  laboratory  ﬁndings  were as  follows  (HES  vs. con-
trols): red  blood  cell  count: 4.2±0.5  T/l  vs.  4.3±0.4
T/l (p=0.94);  hemoglobin:  126.7±18.8  g/l  vs.  130.1±10.2
g/l (p=0.86);  platelet  count:  276.3±176.7×109/l vs.
282.4±158.2×109/l; hematocrit:  36.9±5.5%  vs. 37.8±4.9%;
white blood  cell  count:  16.7±5.8×109/l  vs.  6.8±1.2×109/l
(p=0.02); eosinophil  ratio:  49.0±16.6%  vs.  3.2±2.3%
(p=0.001); and  absolute  eosinophil  count:  8.7±4.8×109/l  vs.
0.4±0.1×109/l (p=0.001).  No  correlations  could  be demon-
strated between  any  of  the laboratory  ﬁndings  and 2D
echocardiographic and  3DSTE  data  in  this  patient  popula-
tion.
The routine  two-dimensional  echocardiographic  data  are
presented in Table  2.  None  of  the controls  or  HES  patients
showed grade  >1  mitral  or  tricuspid  regurgitation.  Only  LA
diameter and  interventricular  septal  thickness  showed  sig-
niﬁcant differences  between  HES  patients  and controls.
The  3DSTE  data  are presented  in Table  3.  Signiﬁcantly
increased maximum  (p=0.01)  and  minimum  (p=0.03)  LA  vol-
umes and LA  volume  before  atrial  contraction  (p=0.01)  and
elevated total  (p=0.02)  and  active (p=0.005)  atrial  stroke
volumes characterizing  LA reservoir  and  booster  pump  func-
tions were found  in HES  patients  as  compared  to  controls
(Table 3). All  emptying  fractions  did not  differ  between
groups. Both  global  and  mean  segmental  peak  CS  were  sig-
niﬁcantly reduced  in HES  patients,  suggesting  decreased  LA
reservoir function  (Table  4).
Discussion
Cardiac  manifestations  are the  major  cause  of  morbidity  in
HES and  follow  three  stages.  The  ﬁrst,  an  acute  necrotic
stage, is  due  to  inﬁltration  of  eosinophils  in  the myocardium
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Table  2  Clinical  and  two-dimensional  echocardiographic  characteristics  of  patients  with  hypereosinophilic  syndrome  and
controls.
HES  patients  (n=10)  Controls  (n=19)  p
Risk  factors
Age (years)  58.1±13.1  51.2±12.6  0.18
Male  gender  (%)  7 (70)  11  (58)  0.69
Body  surface  area  (m2)  1.78±0.13  1.77±0.12  0.92
Body  mass  index  (kg/m2)  26.7±1.1  25.3±1.0  0.09
Two-dimensional  echocardiography
LA diameter  (mm)  39.5±3.5  32.9±2.2  0.0005
LVEDD  (mm) 53.0±11.6 47.4±4.6 0.07
LVEDV  (ml) 120.0±46.8 104.5±22.4 0.24
LVEDV/BSA  (ml/m2) 67.2±25.3 59.4±14.3 0.42
LVEDV/BMI  (ml/[kg/m2])  4.5±1.9  4.1±0.9  0.58
LV  end-systolic  diameter  (mm)  36.1±12.5  31.1±4.6  0.13
LV  end-systolic  volume  (ml) 47.8±25.0  37.7±11.0  0.14
LVESV/BSA  (ml/m2) 26.9±13.9  21.6±7.5  0.32
LVESV/BMI  (ml/[kg/m2]) 1.8±0.9  1.5±0.5  0.39
Interventricular  septum  (mm) 11.0±0.7 8.7±1.7  0.0003
LV  posterior  wall  (mm) 9.5±1.2 9.7±2.5 0.81
LV ejection  fraction  (%) 60.5±12.4 63.9±6.5  0.33
E/A  ratio 1.88±0.16 1.43±0.28 0.05
E/E′ ratio 10.2±3.4 6.53±1.15  0.04
BMI: body mass index; BSA: body surface area; HES: hypereosinophilic syndrome; LA: left atrial; LV: left ventricular; LVEDD: left ventricular
end-diastolic diameter; LVEDV: left ventricular end-diastolic volume; LVESD: left ventricular end-systolic diameter; LVESV: end-systolic
volume.
Table  3  Comparison  of  three-dimensional  speckle  tracking  echocardiography-derived  volumetric  and  volume-based  left  atrial
functional  parameters  of  patients  with  hypereosinophilic  syndrome  and  controls.
HES  patients  (n=10)  Controls  (n=19)  p
Calculated  volumes
Vmax (ml) 72.9  ±  38.8 45.6 ± 15.5  0.01
Vmax/BSA  (ml/m
2) 41.8 ±  25.0 26.0 ± 9.7 0.03
Vmax/BMI  (ml/[kg/m
2]) 2.8 ±  1.5 1.8 ± 0.6 0.03
Vmin (ml)  46.3  ±  33.3  26.0  ± 15.0  0.03
Vmin/BSA  (ml/m
2)  26.8  ±  21.4  14.9  ± 9.7  0.05
Vmin/BMI  (ml/[kg/m
2])  1.7  ±  1.2  1.0  ± 0.6  0.05
VpreA (ml)  62.0  ±  36.0  36.5  ± 16.6  0.01
VpreA/BSA  (ml/m
2)  35.7  ±  23.1  20.9  ± 10.4  0.03
VpreA/BMI  (ml/[kg/m
2])  2.3  ±  1.4  1.4  ± 0.7  0.03
Stroke  volumes
TASV (ml)  26.6  ±  8.5  19.6  ± 6.4  0.02
TASV/BSA  (ml/m2)  15.0  ±  4.9  11.1  ± 3.6  0.04
TASV/BMI  (ml/[kg/m2])  1.0  ±  0.3  0.8  ± 0.3  0.12
PASV  (ml)  10.9  ±  8.2  9.1  ± 5.0  0.47
PASV/BSA  (ml/m2)  6.1  ±  4.6  5.1  ± 2.8  0.61
PASV/BMI  (ml/[kg/m2]) 0.4 ±  0.3  0.4  ± 0.2  0.78
AASV  (ml)  15.7  ±  5.1  10.5  ± 4.0  0.005
AASV/BSA  (ml/m2) 8.9 ±  2.9  5.9  ± 2.3  0.01
AASV/BMI  (ml/[kg/m2])  0.6  ±  0.2  0.4  ± 0.2  0.03
Emptying  fractions
Total atrial  EF  (%)  40.0  ±  10.5  45.0  ± 12.9  0.29
Passive  atrial  EF  (%)  15.9  ±  11.7  21.4  ± 10.8  0.21
Active  atrial  EF  (%)  28.6  ±  7.8  30.5  ± 9.5  0.58
AASV: active atrial stroke volume; BMI: body mass index; BSA: body surface area; EF: emptying fraction; HES: hypereosinophilic syndrome;
LA: left atrial; PASV: passive atrial stroke volume; TASV: total atrial stroke volume; Vmax:  maximum left atrial volume; Vmin: minimum
left atrial volume; VpreA:  left atrial volume before atrial contraction.
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Table  4  Comparison  of  three-dimensional  speckle  tracking  echocardiography-derived  peak  global  and  mean  segmental  strain
parameters  of  patients  with  hypereosinophilic  syndrome  and  controls.
HES  patients  (n=10)  Controls  (n=19)  p
Global  strain  parameters
Radial strain  (%)  --17.7  ±  7.7  --15.7  ±  11.6  0.64
Circumferential  strain  (%)  18.3  ±  6.7  25.6  ±  9.0  0.03
Longitudinal  strain  (%)  21.0  ±  6.2  22.3  ±  8.7  0.68
3D  strain  (%)  --10.1  ±  5.0  --9.3  ±  9.0  0.81
Area  strain  (%)  41.2  ±  13.8  50.7  ±  20.4  0.20
Mean  segmental  strain  parameters
Radial strain  (%) --20.6± 6.1 --19.5  ±  8.1  0.70
Circumferential  strain  (%) 22.2  ±  6.0 31.0  ±  12.1 0.04
Longitudinal strain  (%) 21.8  ±  6.4 25.6  ±  7.5 0.18
3D strain  (%)  --14.7  ±  4.3  --13.7  ±  6.7  0.67
Area  strain  (%)  45.6  ±  13.1  58.3  ±  21.7  0.10
3D: three-dimensional; HES: hypereosinophilic syndrome.
and  is  mostly  asymptomatic.13 The  initial  damage  is  thought
to be caused  by  eosinophilic  granules.  The  intermediate
(thrombotic) phase  is  characterized  by  thrombus  formation
followed by  organization  of the thrombus  into  a thick  layer
of granulation  tissue.  In  the  third,  ﬁbrotic  stage, granu-
lation tissue  changes  into  ﬁbrosis,  sometimes  still  with  a
small inﬂammatory  zone.13 Nowadays  the term  ‘Löfﬂer’s
endomyocarditis’ is used to  describe  the  involvement  of
the heart  in HES  in  the  thrombotic  and  ﬁbrotic  stage.14
Typical  echocardiographic  ﬁndings  in HES  are endocardial
thickening, ﬁbrothrombotic  obliteration  of the  ventricular
apices, and  valvular  regurgitation  due  to restricted  motion
of the  posterior  mitral  leaﬂet  as  assessed  by 2D  Doppler
echocardiography.1--3,13
In  the  present  study,  most HES  patients  had no  known
cardiac disease  or  clinical  signs  of  thrombosis  or  ﬁbrosis
at enrollment  (except  case  5).  They  were  presumably  in
the ﬁrst,  asymptomatic  stage,  therefore  the alterations  in
LA morphology  and  function  would  be  related  solely  to
HES. Only  left  ventricular  hypertrophy  and  dilated  LA  could
be detected  by  conventional  2D  Doppler  echocardiography,
without signiﬁcant  valvular  regurgitation  or  thrombus  for-
mation. 3DSTE  conﬁrmed  LA volume  changes  in all  phases
of LA  function  and  found  alterations  in  both  peak  global
and mean  segmental  LA CS,  suggesting  reduced  reservoir
function and  LA  remodeling.
A wide  variety  of  pathophysiological  changes  may  lead  to
LA remodeling,  with  structural,  functional,  neurohormonal
or other  consequences.15 The  real mechanism  behind  LA
remodeling in  HES  is  not  known,  but  myocyte  necrosis  and
alterations in the extracellular  matrix  and in the  release
of atrial  hormones  due  to  toxic  proteins  from  degranulat-
ing eosinophils  and  diastolic  dysfunction  could  theoretically
explain our  ﬁndings.15
3DSTE  is  a  new  clinical  tool  for  non-invasive  3D  car-
diac chamber  quantiﬁcations  of  the  left ventricle  and
atrium based  on  a  block-matching  algorithm  of  myocar-
dial speckles  during  their  frame-to-frame  motion.4 3DSTE
has been  demonstrated  to  be  useful  for  LA  volumetric7--10
and  strain10--12 assessments,  allowing  more  detailed  assess-
ment of  LA  function  from  the same  3D  dataset.  Different
patterns  in 3DSTE-derived  volume-based  and strain  func-
tional properties  can  be  demonstrated  in different
disorders.  In a  recent 3DSTE  study,  peak  LA  RS  and  LA LS
were found to  be  altered  in hypertrophic  cardiomyopathy,
together with  preserved  LA  CS.10 In another  study,  strains
at all  LA  levels  showed  alterations  in atrial  ﬁbrillation  by
3DSTE.12 In the present  study,  only peak  LA CS  was  decreased
in HES  patients,  while  RS  and  LS  remained  unchanged.  The
real pathological  mechanism  behind  the reason  that  only  LA
CS shows  alterations  in HES  is  not  known,  but  hemodynamic
reasons and  their  relationship  with  LA  ﬁber orientation
cannot be excluded,  beyond  the  above-mentioned  patho-
physiologic factors.
Limitations
Several  important  limitations  of  the assessments  should  be
taken into  account,  including  lower  image  quality  as  com-
pared to  2D  echocardiography.  Only  a limited  number  of
HES patients  were  examined,  which should be considered
when interpreting  the  results.  However,  HES  is a  relatively
rare disease.  Coronary  angiography  was  performed  in one
HES case,  with  a  negative  result.  Moreover,  transesophageal
echocardiography  was  not  performed  to  exclude  thrombi in
HES patients.
Conclusions
Increased  LA  volumes  and  stroke  volumes  were  demon-
strated in HES  patients,  accompanied  by  reduced  LA peak
circumferential strain  as  assessed  by  3DSTE.  These  results
suggest structural  and functional  LA remodeling  in HES
patients.
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